Through inhibiting monocytes infiltration and macrophages accumulation in TME, CCL2 intervention also suppressed the development of several types of tumor and promoted the better prognosis, including esophageal and breast cancers 71, 88. This evidence concerns the gene CCL2 and breast cancer.